Lastly, use of antiviral drugs either before or during anti-TNF therapy would also be expected to lead the incidence of liver enzyme elevation to be underestimated; however, only seven HBsAg+ patients in our study received anti-hepatitis drugs because formal risk management guidelines were not issued in Taiwan until 2012 [11]. The gene discussed is TNF; the disease is Hepatitis.